HomeCompareBKHYY vs PFE

BKHYY vs PFE: Dividend Comparison 2026

BKHYY yields 3.95% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKHYY wins by $1690.50M in total portfolio value
10 years
BKHYY
BKHYY
● Live price
3.95%
Share price
$118.99
Annual div
$4.70
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1690.54M
Annual income
$1,612,138,301.03
Full BKHYY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BKHYY vs PFE

📍 BKHYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKHYYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKHYY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKHYY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKHYY
Annual income on $10K today (after 15% tax)
$335.74/yr
After 10yr DRIP, annual income (after tax)
$1,370,317,555.88/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, BKHYY beats the other by $1,370,295,235.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKHYY + PFE for your $10,000?

BKHYY: 50%PFE: 50%
100% PFE50/50100% BKHYY
Portfolio after 10yr
$845.30M
Annual income
$806,082,279.87/yr
Blended yield
95.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BKHYY
No analyst data
Altman Z
0.4
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKHYY buys
0
PFE buys
0
No recent congressional trades found for BKHYY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKHYYPFE
Forward yield3.95%6.13%
Annual dividend / share$4.70$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$1690.54M$49.6K
Annual income after 10y$1,612,138,301.03$26,258.71
Total dividends collected$1684.93M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BKHYY vs PFE ($10,000, DRIP)

YearBKHYY PortfolioBKHYY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,490$789.98$9,153$693.39+$2.3KBKHYY
2$13,991$1,696.61$8,593$849.25+$5.4KBKHYY
3$18,832$3,861.49$8,336$1,066.78+$10.5KBKHYY
4$29,865$9,715.09$8,437$1,384.80+$21.4KBKHYY
5$60,754$28,798.22$9,013$1,875.40+$51.7KBKHYY
6$174,509$109,502.04$10,306$2,680.72+$164.2KBKHYY
7$774,635$587,911.08$12,820$4,101.38+$761.8KBKHYY
8$5,706,820$4,877,959.75$17,673$6,826.70+$5.69MBKHYY
9$73,277,213$67,170,916.41$27,543$12,591.86+$73.25MBKHYY
10$1,690,544,919$1,612,138,301.03$49,560$26,258.71+$1690.50MBKHYY

BKHYY vs PFE: Complete Analysis 2026

BKHYYStock

Bank Hapoalim B.M., together with its subsidiaries, provides various banking and financial products and services in Israel and internationally. It operates through Corporate Banking, Retail Banking, and Financial Markets and International Banking divisions. The company offers account-management services, credit for various purposes, deposits, and savings plans, and capital-market service; securities, and currencies and derivatives trading services; securities custody services; research, consulting, and advisory services; pension advisory and retirement planning services; and housing loans. It also provides credit for routine operations and investment financing, guarantees, letters of credit, foreign trade, and transactions in financial and derivative instruments, as well as investment services in various channels, such as foreign currency, shekels, securities, etc. In addition, the company offers financing for infrastructure projects, foreign trade and international trade financing, and project financing services; foreign trade transactions and transactions in financial derivatives; financing of working capital; syndication; credit-risk sales; financing of construction projects; dealing-room services; federal deposit insurance; and credit cards services. Further, it provides clearing of payment, asset management, investment portfolio management, investment banking, underwriting, and issuance management services. The company serves households, private-banking customers, foreign residents, small businesses, financial-asset managers, middle-market business clients, and large corporations through 175 branches, 601 external and 131 internal automatic teller machines, 126 external and 216 internal check-deposit machines, 30 information stations, 316 self-service stations, and 119 night safes. Bank Hapoalim B.M. was founded in 1921 and is based in Tel Aviv, Israel.

Full BKHYY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BKHYY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKHYY vs SCHDBKHYY vs JEPIBKHYY vs OBKHYY vs KOBKHYY vs MAINBKHYY vs JNJBKHYY vs MRKBKHYY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.